Alinamin Pharmaceutical Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Alinamin Pharmaceutical Co., Ltd. - overview
Established
2016
Location
Tokyo, -, Japan
Primary Industry
Pharmaceuticals
About
Established in 2016 and based in Tokyo, Japan, Alinamin Pharmaceutical Co. , Ltd. , formerly known as Takeda Consumer Healthcare Company Limited, develops, manufactures and sells over the counter products, quasi-drugs, and related items.
Current Investors
Blackstone Group
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development, Medicinal Chemicals & Botanicals
Website
www.takeda-chc.co.jp
Verticals
E-commerce, Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Alinamin Pharmaceutical Co., Ltd. - timeline of key events
Alinamin Pharmaceutical Co., Ltd. - financials
| Fiscal Year Ended | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 |
|---|---|---|---|---|---|
| Revenue (USD) | 79,921,000,000 | 64,139,000,000 | - | - | - |
| % Revenue Growth (YoY) | - | (19.7%) | - | - | - |
| EBITDA (USD) | 13,160,000,000 | 12,945,000,000 | - | - | - |
| Operating Income (USD) | 13,160,000,000 | 12,945,000,000 | - | - | - |
| Operating Margin | 16.5% | 20.2% | - | - | - |
| % EBITDA Margin | 16.5% | 20.2% | - | - | - |
| NET Income (USD) | 8,828,000,000 | 9,624,000,000 | - | - | - |
| % Net Margin | 11.0% | 15.0% | - | - | - |
Alinamin Pharmaceutical Co., Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | Alinamin Pharmaceutical Co., Ltd. | - | ||||||||
| Buyout | Completed | Alinamin Pharmaceutical Co., Ltd. | - |
Displaying 1 - 2 of 2
Alinamin Pharmaceutical Co., Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.